BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boutin S, Hildebrand D, Boulant S, Kreuter M, Rüter J, Pallerla SR, Velavan TP, Nurjadi D. Host factors facilitating SARS-CoV-2 virus infection and replication in the lungs. Cell Mol Life Sci 2021;78:5953-76. [PMID: 34223911 DOI: 10.1007/s00018-021-03889-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Tang SGH, Hadi MHH, Arsad SR, Ker PJ, Ramanathan S, Afandi NAM, Afzal MM, Yaw MW, Krishnan PS, Chen CP, Tiong SK. Prerequisite for COVID-19 Prediction: A Review on Factors Affecting the Infection Rate. IJERPH 2022;19:12997. [DOI: 10.3390/ijerph192012997] [Reference Citation Analysis]
2 Bahl AS, Verma VK, Bhatia J, Arya DS. Integrating in silico and in vivo approach for investigating the role of polyherbal oil in prevention and treatment of COVID-19 infection. Chem Biol Interact 2022;367:110179. [PMID: 36113631 DOI: 10.1016/j.cbi.2022.110179] [Reference Citation Analysis]
3 Zhou Y, Zheng R, Liu D, Liu S, Disoma C, Li S, Liao Y, Chen Z, Du A, Dong Z, Zhang Y, Liu P, Razzaq A, Chen D, Chen X, Zhong X, Liu S, Tao S, Liu Y, Xu L, Deng X, Li J, Jiang T, Zhao J, Li S, Xia Z. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b. J Virol 2022;:e0074122. [PMID: 35980206 DOI: 10.1128/jvi.00741-22] [Reference Citation Analysis]
4 Castelán-sánchez HG, Delaye L, Inward RPD, Dellicour S, Gutierrez B, de la Vina NM, Pybus OG, de Anda Jáuregui G, Guzmán P, Garrido MF, Fontanelli Ó, Rosales MH, Meneses A, Olmedo-alvarez G, Herrera-estrella A, Boukadida C, Sanchez-flores A, Muñoz-medina JE, Comas-garcía A, Gómez-gil B, Zárate S, Taboada B, López S, Arias CF, Kraemer MU, Lazcano A, Escalera-zamudio M. “Comparing the evolutionary dynamics of predominant SARS-CoV-2 virus lineages co-circulating in Mexico”.. [DOI: 10.1101/2022.07.05.498834] [Reference Citation Analysis]
5 Rajendran R, Chathambath A, Al-Sehemi AG, Pannipara M, Unnikrishnan MK, Aleya L, Raghavan RP, Mathew B. Critical role of nitric oxide in impeding COVID-19 transmission and prevention: a promising possibility. Environ Sci Pollut Res Int 2022;29:38657-72. [PMID: 35258738 DOI: 10.1007/s11356-022-19148-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Liu C, Lee J, Ta C, Soroush A, Rogers J, Kim JH, Natarajan K, Zucker J, Perl Y, Weng C. A Retrospective Analysis of Risk Factors Associated with the SARS-CoV-2 Breakthrough in Fully mRNA Vaccinated Individuals. JMIR Public Health Surveill 2022. [PMID: 35486806 DOI: 10.2196/35311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chen L, Qu J, Kalyani FS, Zhang Q, Fan L, Fang Y, Li Y, Xiang C. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-021-04096-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
8 Chen LF, Yang CD, Cheng XB. Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection. Front Immunol 2021;12:788368. [PMID: 35003106 DOI: 10.3389/fimmu.2021.788368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Gómez-icazbalceta G, Hussain Z, Vélez-alavez M. In silico evidence of superantigenic features in ORF8 protein from COVID-19.. [DOI: 10.1101/2021.12.14.472240] [Reference Citation Analysis]
10 Liu C, Lee J, Ta C, Soroush A, Rogers JR, Kim JH, Natarajan K, Zucker J, Perl Y, Weng C. Risk Factors Associated With SARS-CoV-2 Breakthrough Infections in Fully mRNA-Vaccinated Individuals: Retrospective Analysis (Preprint).. [DOI: 10.2196/preprints.35311] [Reference Citation Analysis]
11 Velavan TP, Pallerla SR, Rüter J, Augustin Y, Kremsner PG, Krishna S, Meyer CG. Host genetic factors determining COVID-19 susceptibility and severity. EBioMedicine 2021;72:103629. [PMID: 34655949 DOI: 10.1016/j.ebiom.2021.103629] [Cited by in Crossref: 53] [Cited by in F6Publishing: 25] [Article Influence: 53.0] [Reference Citation Analysis]
12 Liu C, Lee J, Ta C, Soroush A, Rogers JR, Kim JH, Natarajan K, Zucker J, Weng C. A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections - Risk Factors and Vaccine Effectiveness. medRxiv 2021:2021. [PMID: 34642696 DOI: 10.1101/2021.10.05.21264583] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 22.0] [Reference Citation Analysis]
13 Mishra B, Ranjan J, Ravindra A. Gender and genetic factors impacting COVID-19 severity. J Family Med Prim Care 2021;10:3956. [DOI: 10.4103/jfmpc.jfmpc_769_21] [Reference Citation Analysis]